Compugen (CGEN) Assets Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.51% |
| Sep 30, 2025 | -7.35% |
| Jun 30, 2025 | -6.10% |
| Mar 31, 2025 | -2.52% |
| Dec 31, 2024 | 16.42% |
| Sep 30, 2024 | 16.59% |
| Jun 30, 2024 | 17.95% |
| Mar 31, 2024 | 17.45% |
| Dec 31, 2023 | 17.94% |
| Sep 30, 2023 | 5.79% |
| Jun 30, 2023 | 8.59% |
| Mar 31, 2023 | 16.63% |
| Dec 31, 2022 | 19.44% |
| Sep 30, 2022 | 16.11% |
| Jun 30, 2022 | 14.68% |
| Mar 31, 2022 | 13.51% |
| Dec 31, 2021 | 13.19% |
| Sep 30, 2021 | 9.26% |
| Jun 30, 2021 | 7.78% |
| Mar 31, 2021 | 7.29% |
| Dec 31, 2020 | 6.85% |
| Sep 30, 2020 | 8.11% |
| Jun 30, 2020 | 7.16% |
| Mar 31, 2020 | 3.87% |
| Dec 31, 2019 | -14.11% |
| Sep 30, 2019 | -12.94% |
| Jun 30, 2019 | -16.87% |
| Mar 31, 2019 | -16.55% |
| Dec 31, 2018 | -1.28% |
| Sep 30, 2018 | -1.63% |
| Jun 30, 2018 | 6.64% |
| Mar 31, 2018 | 3.04% |
| Dec 31, 2017 | 6.03% |
| Sep 30, 2017 | 10.90% |
| Jun 30, 2017 | 13.15% |
| Mar 31, 2017 | 14.58% |
| Dec 31, 2016 | 19.59% |
| Sep 30, 2016 | 22.26% |
| Jun 30, 2016 | 21.29% |
| Mar 31, 2016 | 21.57% |
| Dec 31, 2015 | 22.19% |
| Sep 30, 2015 | 26.76% |
| Jun 30, 2015 | 28.96% |
| Mar 31, 2015 | 27.88% |
| Dec 31, 2014 | 30.67% |
| Sep 30, 2014 | 56.98% |
| Jun 30, 2014 | 55.17% |
| Mar 31, 2014 | 60.58% |